1. Sutton, B.M., E. McGusty, D.T. Walz, andM.J. DiMartino. 1972. Oral gold. Antiarthritic properties of alkyphosphine gold coordination complexes.J. Med. Chem. 15:1095.
2. Finkelstein, A.E., D.T. Walz, V. Batista, M. Mizraji, F. Roisman, andA. Misher. 1976. Auranofin. New oral gold compound for treatment of rheumatoid arthritis.Ann. Rheum. Dis. 35:251.
3. Berglöf, F.-E., K. Berglöf, andD.T. Walz. 1977. Auranofin: An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis.Arthritis Rheum. 20:108.
4. DiMartino, M.J., D.T. Walz, C.E. Wolff, andW.A. Mann. 1974. Inhibition of lysosomal enzyme release from rat leukocytes by a new gold compound-SK&F D-39162.Fed. Proc. 33:558.
5. Walz, D.T., M.J. DiMartino, L.W. Chakrin, B.M. Sutton, andA. Misher. 1976. Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: SK&F D-39162.J. Pharmacol. Exp. Ther. 197:142.